Two Sigma Securities’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,416
Closed -$13.7K 2214
2024
Q4
$13.7K Buy
+1,416
New +$13.7K ﹤0.01% 1197
2024
Q1
Sell
-1,565
Closed -$24.5K 2253
2023
Q4
$24.5K Buy
+1,565
New +$24.5K ﹤0.01% 1126